• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超声引导经皮射频消融与开放性甲状腺切除术治疗低危甲状腺微小乳头状癌的比较:倾向评分匹配研究。

Comparison of ultrasound guided percutaneous radiofrequency ablation and open thyroidectomy in the treatment of low-risk papillary thyroid microcarcinoma: A propensity score matching study.

机构信息

Department of Ultrasound in Medicine, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.

Department of Interventional Ultrasound, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.

出版信息

Clin Hemorheol Microcirc. 2022;80(2):73-81. doi: 10.3233/CH-201087.

DOI:10.3233/CH-201087
PMID:33579830
Abstract

PURPOSE

The aim of this study was to evaluate the efficacy, safety and costs of ultrasound guided percutaneous radiofrequency ablation (RFA) versus open thyroidectomy for treating low-risk papillary thyroid microcarcinoma (PTMC) by using propensity score matching (PSM).

PATIENTS AND METHODS

157 patients who underwent RFA and 206 patients who underwent surgery for low-risk PTMC were included in the study. The patients were followed up at 1, 3, 6, 12 months after treatment, and every half year thereafter. A 1:1 PSM method was applied to balance the pretreatment data of the two groups. In the matched group (133 patients for each), the operative time, length of hospital stay, hospitalization expenses, cosmetic results, complications were assessed and compared between two groups.

RESULTS

At last follow-up, 39 tumors (29.3%) in the RFA group completely disappeared. Between the well-matched groups, no local recurrence, lymph node metastasis or distant metastases were detected in either group during the follow-up period. After matching, the operation time and hospitalization time in RFA group were shorter than those in surgery group (both P < 0.05). The average hospitalization expense of the patients in RFA group was cheaper than that in surgery group (P < 0.05). Moreover, the cosmetic score was found to be higher in RFA group than that observed in surgery group (P < 0.05).

CONCLUSIONS

RFA may be an effective and safe method for treating low-risk PTMC with a superior advantage of being low-cost and having a shorter operation time and hospital stay versus surgery.

摘要

目的

本研究旨在通过倾向评分匹配(PSM)评估超声引导经皮射频消融(RFA)与开放甲状腺切除术治疗低危甲状腺微小乳头状癌(PTMC)的疗效、安全性和成本。

患者与方法

纳入 157 例行 RFA 治疗和 206 例行手术治疗的低危 PTMC 患者。治疗后 1、3、6、12 个月及此后每半年对患者进行随访。采用 1:1 PSM 方法平衡两组患者的治疗前数据。在匹配组(每组 133 例)中,评估并比较两组患者的手术时间、住院时间、住院费用、美容效果和并发症。

结果

在最后一次随访时,RFA 组 39 个肿瘤(29.3%)完全消失。在匹配组中,在随访期间,两组均未发现局部复发、淋巴结转移或远处转移。匹配后,RFA 组的手术时间和住院时间均短于手术组(均 P<0.05)。RFA 组患者的平均住院费用低于手术组(P<0.05)。此外,RFA 组的美容评分高于手术组(P<0.05)。

结论

RFA 可能是一种治疗低危 PTMC 的有效且安全的方法,与手术相比,其具有成本较低、手术时间和住院时间较短的优势。

相似文献

1
Comparison of ultrasound guided percutaneous radiofrequency ablation and open thyroidectomy in the treatment of low-risk papillary thyroid microcarcinoma: A propensity score matching study.超声引导经皮射频消融与开放性甲状腺切除术治疗低危甲状腺微小乳头状癌的比较:倾向评分匹配研究。
Clin Hemorheol Microcirc. 2022;80(2):73-81. doi: 10.3233/CH-201087.
2
Ultrasound-Guided Radiofrequency Ablation Versus Thyroid Lobectomy for Low-Risk Papillary Thyroid Microcarcinoma: A Propensity-Matched Cohort Study of 884 Patients.超声引导下射频消融术与甲状腺叶切除术治疗低危甲状腺微小乳头状癌:884例患者的倾向评分匹配队列研究
Thyroid. 2021 Nov;31(11):1662-1672. doi: 10.1089/thy.2021.0100. Epub 2021 Sep 17.
3
Ultrasound-Guided Radiofrequency Ablation Versus Surgery for Low-Risk Papillary Thyroid Microcarcinoma: Results of Over 5 Years' Follow-Up.超声引导下射频消融与手术治疗低危甲状腺微小乳头状癌:5 年以上随访结果。
Thyroid. 2020 Mar;30(3):408-417. doi: 10.1089/thy.2019.0147. Epub 2020 Feb 6.
4
Long-Term Follow-Up Results of Ultrasound-Guided Radiofrequency Ablation for Low-Risk Papillary Thyroid Microcarcinoma: More Than 5-Year Follow-Up for 84 Tumors.超声引导射频消融治疗低危甲状腺微小乳头状癌的长期随访结果:84 个肿瘤的 5 年以上随访。
Thyroid. 2020 Dec;30(12):1745-1751. doi: 10.1089/thy.2020.0106. Epub 2020 Jun 8.
5
Clinical outcomes of radiofrequency ablation for multifocal papillary thyroid microcarcinoma versus unifocal papillary thyroid microcarcinoma: a propensity-matched cohort study.多灶性与单灶性甲状腺微小乳头状癌射频消融的临床结局:一项倾向匹配队列研究
Eur Radiol. 2022 Feb;32(2):1216-1226. doi: 10.1007/s00330-021-08133-z. Epub 2021 Aug 6.
6
Quality of Life in Papillary Thyroid Microcarcinoma Patients Undergoing Radiofrequency Ablation or Surgery: A Comparative Study.射频消融与手术治疗甲状腺微小乳头状癌患者的生活质量比较:一项对照研究。
Front Endocrinol (Lausanne). 2020 May 15;11:249. doi: 10.3389/fendo.2020.00249. eCollection 2020.
7
Radiofrequency ablation for capsular-located versus noncapsular-located papillary thyroid microcarcinoma: a propensity score matching study of 1095 patients.甲状腺微小乳头状癌位于被膜内与非被膜内的射频消融治疗:一项对1095例患者的倾向评分匹配研究
Eur Radiol. 2024 Jul;34(7):4716-4726. doi: 10.1007/s00330-023-10490-w. Epub 2024 Jan 3.
8
One year follow-up of US-Guided radiofrequency ablation for low-risk papillary thyroid microcarcinoma: The first experience in Taiwan.台湾地区超声引导下射频消融治疗低危甲状腺微小乳头状癌的一年随访:初步经验
J Formos Med Assoc. 2022 Aug;121(8):1406-1413. doi: 10.1016/j.jfma.2021.09.026. Epub 2021 Oct 15.
9
Comparison of the efficacy and safety of ultrasound-guided radiofrequency ablation and microwave ablation for the treatment of unifocal papillary thyroid microcarcinoma: a retrospective study.超声引导下射频消融与微波消融治疗单发甲状腺微小乳头状癌的疗效与安全性比较:一项回顾性研究。
Int J Hyperthermia. 2024;41(1):2287964. doi: 10.1080/02656736.2023.2287964. Epub 2024 Jan 15.
10
Radiofrequency ablation for papillary thyroid microcarcinoma close to the thyroid capsule versus far from the thyroid capsule: a retrospective study.射频消融治疗靠近甲状腺被膜与远离甲状腺被膜的甲状腺微小乳头状癌:一项回顾性研究。
Endokrynol Pol. 2024;75(1):35-41. doi: 10.5603/ep.95964.

引用本文的文献

1
The feasibility of using a multivariate regression model incorporating ultrasound findings and serum markers to predict thyroid cancer metastasis.使用包含超声检查结果和血清标志物的多元回归模型预测甲状腺癌转移的可行性。
Front Endocrinol (Lausanne). 2024 Nov 18;15:1461865. doi: 10.3389/fendo.2024.1461865. eCollection 2024.
2
Comparison of radiofrequency ablation and surgery for thyroid papillary microcarcinoma: efficacy, safety and life quality.射频消融与手术治疗甲状腺微小乳头状癌的疗效、安全性及生活质量比较。
Front Endocrinol (Lausanne). 2024 Jul 12;15:1352503. doi: 10.3389/fendo.2024.1352503. eCollection 2024.
3
Advances in clinical research on ultrasound-guided radiofrequency ablation for papillary thyroid microcarcinoma.
超声引导下射频消融治疗甲状腺微小乳头状癌的临床研究进展
Front Oncol. 2024 Jul 8;14:1422634. doi: 10.3389/fonc.2024.1422634. eCollection 2024.
4
Efficacy and safety of thermal ablation modalities for the treatment of papillary thyroid microcarcinoma: Systematic Review and network meta-analysis.热消融方式治疗甲状腺微小乳头状癌的疗效与安全性:系统评价与网状Meta分析
Heliyon. 2024 Jan 30;10(3):e25536. doi: 10.1016/j.heliyon.2024.e25536. eCollection 2024 Feb 15.
5
Important parameters should be paid attention in PTMC radiofrequency ablation.在甲状腺微小乳头状癌射频消融中应注意重要参数。
Sci Rep. 2023 Aug 18;13(1):13450. doi: 10.1038/s41598-023-40532-8.
6
Modern Surgical Techniques of Thyroidectomy and Advances in the Prevention and Treatment of Perioperative Complications.现代甲状腺切除术的外科技术及围手术期并发症的防治进展
Cancers (Basel). 2023 May 26;15(11):2931. doi: 10.3390/cancers15112931.
7
Management of surgical diseases of thyroid gland indications of the United Italian Society of Endocrine Surgery (SIUEC).意大利内分泌外科学会(SIUEC)关于甲状腺外科疾病管理的适应证。
Updates Surg. 2023 Sep;75(6):1393-1417. doi: 10.1007/s13304-023-01522-7. Epub 2023 May 18.
8
A systematic review and meta-analysis comparing tumor progression and complications between radiofrequency ablation and thyroidectomy for papillary thyroid carcinoma.一项比较射频消融术与甲状腺切除术治疗甲状腺乳头状癌的肿瘤进展和并发症的系统评价与荟萃分析。
Front Oncol. 2022 Nov 30;12:994728. doi: 10.3389/fonc.2022.994728. eCollection 2022.
9
Radiofrequency Ablation of Indeterminate Thyroid Nodules: The First North American Comparative Analysis.射频消融治疗不确定甲状腺结节:首次北美比较分析。
Int J Mol Sci. 2022 Sep 29;23(19):11493. doi: 10.3390/ijms231911493.
10
Safety and efficacy of ultrasound-guided thermal ablation in treating T1aN0M0 and T1bN0M0 papillary thyroid carcinoma: A meta-analysis.超声引导热消融治疗 T1aN0M0 和 T1bN0M0 甲状腺乳头状癌的安全性和有效性:一项荟萃分析。
Front Endocrinol (Lausanne). 2022 Jul 27;13:952113. doi: 10.3389/fendo.2022.952113. eCollection 2022.